Weeks after raising one of the industry’s largest Series A rounds of the year, biotech veteran-turned-real estate developer Arie Belldegrun’s venture capital firm has closed a $600 million round for new life sciences investments.
Boston-based Vida Ventures closed its second fundraising Thursday, almost two years after raising $255 million for its first fund. The new fund brings the total money being managed by Vida to approximately $1 billion, according to the company.
Vida has backed 14…
